{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Doxycycline (0.25 - 16 \u03bcg/mL)",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent doxycycline (0.25 - 16 \u03bcg/mL) - Gram-positive ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K082913",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020321",
        "K060324",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "December 5, 2008",
    "Summary Letter Received Date": "September 30, 2008",
    "Submission Date": "September 29, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short Term Incubation Cycle Antimicrobial Susceptibility Device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Doxycycline"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of most aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria",
        "Gram-positive bacteria isolates (Staphylococcus, Enterococcus, Streptococcus)",
        "Gram-negative bacteria isolates (Enterobacteriaceae, Non-Enterobacteriaceae)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Automated broth-based microdilution",
        "Redox indicator measurement",
        "Bacterial turbidity measurement"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System with Doxycycline for automated antimicrobial susceptibility testing of Gram-positive isolates",
    "Indications for Use Summary": "For in vitro quantitative determination of antimicrobial susceptibility by MIC of most Gram-negative and Gram-positive bacterial isolates from pure culture, including Staphylococcus, Enterococcus, and Streptococcus, using panels containing doxycycline",
    "fda_folder": "Microbiology"
}